{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T14:58:50Z","timestamp":1778684330597,"version":"3.51.4"},"reference-count":40,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T00:00:00Z","timestamp":1669939200000},"content-version":"vor","delay-in-days":5358,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1111\/j.1600-6143.2007.02136.x","type":"journal-article","created":{"date-parts":[[2008,3,3]],"date-time":"2008-03-03T19:03:16Z","timestamp":1204570996000},"page":"803-810","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Pharmacokinetics and Pharmacodynamics of Cinacalcet in Patients with Hyperparathyroidism After Renal Transplantation"],"prefix":"10.1016","volume":"8","author":[{"given":"A.L.","family":"Serra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.C","family":"Braun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Starke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Savoca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Hersberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Russmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Corti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.P.","family":"W\u00fcthrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1111\/j.1600-6143.2007.02136.x_bib1","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1399-0012.1995.tb00336.x","article-title":"Normocalcemic hyperparathyroidism associated with relatively low 1,25 vitamin D levels post-renal transplant can be successfully treated with oral calcitriol","volume":"9","author":"Lobo","year":"1995","journal-title":"Clin Transplant"},{"key":"10.1111\/j.1600-6143.2007.02136.x_bib2","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1093\/oxfordjournals.ndt.a027843","article-title":"Sequential changes of biochemical bone parameters after kidney transplantation","volume":"13","author":"Reinhardt","year":"1998","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1600-6143.2007.02136.x_bib3","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0272-6386(12)70118-X","article-title":"Musculoskeletal complications after renal transplantation: Pathogenesis and treatment","volume":"19","author":"Julian","year":"1992","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1600-6143.2007.02136.x_bib4","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1111\/j.1523-1755.2005.00303.x","article-title":"Clinical impact of preexisting vascular calcifications on mortality after renal transplantation","volume":"67","author":"Hernandez","year":"2005","journal-title":"Kidney Int"},{"key":"10.1111\/j.1600-6143.2007.02136.x_bib5","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1111\/j.1600-6143.2005.00938.x","article-title":"Early calcification of renal allografts detected by protocol biopsies: Causes and clinical implications","volume":"5","author":"Gwinner","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2007.02136.x_bib6","doi-asserted-by":"crossref","first-page":"374","DOI":"10.5414\/CNP65374","article-title":"Treatment of severe hypercalcemia due to refractory hyperparathyroidism in renal transplant patients with the calcimimetic agent cinacalcet","volume":"65","author":"Apostolou","year":"2006","journal-title":"Clin Nephrol"},{"key":"10.1111\/j.1600-6143.2007.02136.x_bib7","doi-asserted-by":"crossref","first-page":"3514","DOI":"10.1016\/j.transproceed.2006.10.133","article-title":"Hypercalcemia due to resistant hyperparathyroidism in renal transplant patients treated with the calcimimetic agent cinacalcet","volume":"38","author":"Apostolou","year":"2006","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1600-6143.2007.02136.x_bib8","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1097\/01.tp.0000253429.33198.2f","article-title":"Preliminary experience with cinacalcet use in persistent secondary hyperparathyroidism after kidney transplantation","volume":"83","author":"El-Amm","year":"2007","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2007.02136.x_bib9","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1111\/j.1600-6143.2006.01475.x","article-title":"Early and severe hyperparathyroidism associated with hypercalcemia after renal transplant treated with cinacalcet","volume":"6","author":"Leca","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2007.02136.x_bib10","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1093\/ndt\/gfl560","article-title":"Effective control of persistent hyperparathyroidism with cinacalcet in renal allograft recipients","volume":"22","author":"Serra","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1600-6143.2007.02136.x_bib11","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1093\/ndt\/gfh925","article-title":"Successful treatment of hypercalcemia with cinacalcet in renal transplant recipients with persistent hyperparathyroidism","volume":"20","author":"Serra","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1600-6143.2007.02136.x_bib12","doi-asserted-by":"crossref","first-page":"323","DOI":"10.2215\/CJN.00500705","article-title":"Improvement in hypercalcemia with cinacalcet after kidney transplantation","volume":"1","author":"Srinivas","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1111\/j.1600-6143.2007.02136.x_bib13","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1097\/01.tp.0000232452.80018.ad","article-title":"Cinacalcet chloride is efficient and safe in renal transplant recipients with posttransplant hyperparathyroidism","volume":"82","author":"Szwarc","year":"2006","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2007.02136.x_bib14","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1093\/ndt\/gfh924","article-title":"The calcimimetic cinacalcet normalizes serum calcium in renal transplant patients with persistent hyperparathyroidism","volume":"20","author":"Kruse","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1600-6143.2007.02136.x_bib15","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1093\/ndt\/gfm270","article-title":"Effect of cinacalcet cessation in renal transplant recipients with persistent hyperparathyroidism","volume":"22","author":"Kruse","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1600-6143.2007.02136.x_bib16","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1053\/j.ajkd.2004.08.029","article-title":"Pharmacokinetics, pharmacodynamics, and safety of cinacalcet hydrochloride in hemodialysis patients at doses up to 200 mg once daily","volume":"44","author":"Harris","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1600-6143.2007.02136.x_bib17","doi-asserted-by":"crossref","first-page":"297","DOI":"10.5858\/2005-129-297-CMSOTA","article-title":"Creatinine measurement: State of the art in accuracy and interlaboratory harmonization","volume":"129","author":"Miller","year":"2005","journal-title":"Arch Pathol Lab Med"},{"key":"10.1111\/j.1600-6143.2007.02136.x_bib18","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","article-title":"A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group","volume":"130","author":"Levey","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1600-6143.2007.02136.x_bib19","first-page":"124","article-title":"In vitro metabolism and predicition of drug-drug interactions of the calcimimetic agent cinacalcet HCL","volume":"37","author":"Bajpai","year":"2005","journal-title":"Drug Metab Rev"},{"key":"10.1111\/j.1600-6143.2007.02136.x_bib20","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00228-006-0129-8","article-title":"Pharmacokinetics of desipramine HCl when administered with cinacalcet HCl","volume":"63","author":"Harris","year":"2007","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1111\/j.1600-6143.2007.02136.x_bib21","doi-asserted-by":"crossref","first-page":"495","DOI":"10.2165\/00003088-200746060-00003","article-title":"Pharmacokinetics of cinacalcet hydrochloride when administered with ketoconazole","volume":"46","author":"Harris","year":"2007","journal-title":"Clin Pharmacokinet"},{"key":"10.1111\/j.1600-6143.2007.02136.x_bib22","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1111\/j.1600-6143.2004.00539.x","article-title":"CYP3A4 and P-glycoprotein activity in healthy controls and transplant patients on cyclosporin vs. tacrolimus vs. sirolimus","volume":"4","author":"Lemahieu","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2007.02136.x_bib23","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1200\/JCO.1994.12.8.1584","article-title":"Clinical modulation of multidrug resistance in multiple myeloma: Effect of cyclosporine on resistant tumor cells","volume":"12","author":"Sonneveld","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1111\/j.1600-6143.2007.02136.x_bib24","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1124\/jpet.103.061614","article-title":"Inhibition of organic anion transporting polypeptide-mediated hepatic uptake is the major determinant in the pharmacokinetic interaction between bosentan and cyclosporin A in the rat","volume":"308","author":"Treiber","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1111\/j.1600-6143.2007.02136.x_bib25","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/mc.2940130302","article-title":"Overlapping substrate specificities and tissue distribution of cytochrome P450 3A and P-glycoprotein: Implications for drug delivery and activity in cancer chemotherapy","volume":"13","author":"Wacher","year":"1995","journal-title":"Mol Carcinog"},{"key":"10.1111\/j.1600-6143.2007.02136.x_bib26","doi-asserted-by":"crossref","first-page":"5644","DOI":"10.1210\/jc.2002-021597","article-title":"The calcimimetic cinacalcet normalizes serum calcium in subjects with primary hyperparathyroidism","volume":"88","author":"Shoback","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1600-6143.2007.02136.x_bib27","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1210\/jc.2004-0842","article-title":"Cinacalcet hydrochloride maintains long-term normocalcemia in patients with primary hyperparathyroidism","volume":"90","author":"Peacock","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1600-6143.2007.02136.x_bib28","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1046\/j.1523-1755.2003.00720.x","article-title":"The calcimimetic AMG 073 reduces parathyroid hormone and calcium x phosphorus in secondary hyperparathyroidism","volume":"63","author":"Lindberg","year":"2003","journal-title":"Kidney Int"},{"key":"10.1111\/j.1600-6143.2007.02136.x_bib29","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1681\/ASN.V1341017","article-title":"The Calcimimetic agent AMG 073 lowers plasma parathyroid hormone levels in hemodialysis patients with secondary hyperparathyroidism","volume":"13","author":"Goodman","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1600-6143.2007.02136.x_bib30","first-page":"G122","article-title":"Identification and localization of extracellular Ca2+-sensing receptor in rat intestine","volume":"274","author":"Chattopadhyay","year":"1998","journal-title":"Am J Physiol"},{"key":"10.1111\/j.1600-6143.2007.02136.x_bib31","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1124\/jpet.103.057273","article-title":"Pharmacodynamics of the type II calcimimetic compound cinacalcet HCl","volume":"308","author":"Nemeth","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1111\/j.1600-6143.2007.02136.x_bib32","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1038\/sj.ki.5000324","article-title":"Effect of cinacalcet on urine calcium excretion and supersaturation in genetic hypercalciuric stone-forming rats","volume":"69","author":"Bushinsky","year":"2006","journal-title":"Kidney Int"},{"key":"10.1111\/j.1600-6143.2007.02136.x_bib33","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1111\/j.1523-1755.2005.00302.x","article-title":"Urinary calcium is a determinant of bone mineral density in elderly men participating in the InCHIANTI study","volume":"67","author":"Vezzoli","year":"2005","journal-title":"Kidney Int"},{"key":"10.1111\/j.1600-6143.2007.02136.x_bib34","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1172\/JCI106770","article-title":"Renal effects of calcitonin and parathyroid extract in man. Studies in hypoparathyroidism","volume":"50","author":"Haas","year":"1971","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1600-6143.2007.02136.x_bib35","first-page":"473","article-title":"Rehydration in the treatment of severe hypercalcaemia","volume":"50","author":"Hosking","year":"1981","journal-title":"Q J Med"},{"key":"10.1111\/j.1600-6143.2007.02136.x_bib36","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1073\/pnas.95.4.1909","article-title":"Parathyroid hormone leads to the lysosomal degradation of the renal type II Na\/Pi cotransporter","volume":"95","author":"Pfister","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1111\/j.1600-6143.2007.02136.x_bib37","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/j.1523-1755.2005.67139.x","article-title":"Achieving NKF-K\/DOQI bone metabolism and disease treatment goals with cinacalcet HCl","volume":"67","author":"Moe","year":"2005","journal-title":"Kidney Int"},{"key":"10.1111\/j.1600-6143.2007.02136.x_bib38","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1159\/000046093","article-title":"Renal mineral handling in normal rats treated with sevelamer hydrochloride (Renagel), a noncalcemic phosphate binder","volume":"89","author":"Nagano","year":"2001","journal-title":"Nephron"},{"key":"10.1111\/j.1600-6143.2007.02136.x_bib39","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1093\/ndt\/gfl583","article-title":"Decreased renal transplant function after parathyroidectomy","volume":"22","author":"Schwarz","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1600-6143.2007.02136.x_bib40","first-page":"1356","article-title":"Effects of PTH (1\u201334) on blood pressure, renal function, and hormones in essential hypertension: The altered pattern of reactivity may counteract raised blood pressure","volume":"10","author":"Jespersen","year":"1997","journal-title":"Am J Hypertens"}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-6143.2007.02136.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522056234?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522056234?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1600-6143.2007.02136.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T04:43:35Z","timestamp":1761626615000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1600613522056234"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["S1600613522056234"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-6143.2007.02136.x","relation":{},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2008,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacokinetics and Pharmacodynamics of Cinacalcet in Patients with Hyperparathyroidism After Renal Transplantation","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/j.1600-6143.2007.02136.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}